Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT04683120
Eligibility Criteria:
Inclusion Criteria:
* A) Age18 and over
* B) EnglishSpeaking
* C) Able to read and understand consent
* D) All patient's candidate for lumpectomy
* E) Recurrent cancer patients requiring lumpectomy
* F) All stages and grades of cancer as long as patient is lumpectomy candidate
* G) Margin1(S)
* H) Margin 2(I)
* I) Margin 3 (M)
* J) Margin 4 (L)
* K) Margin5(P)
* L) Margin 6 (A)
Exclusion Criteria: Exclusion criteria includes any patients with autoimmune disease affecting breast tissue anyone receiving neoadjuvant chemotherapy prior to lumpectomy, any patient undergoing mastectomy.
* A) Extensively damaged tissue
* B) Abnormal tissue(auto immune disease)
* C) Neoadjuvant treated breast
* D) Mastectomy
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT04683120
Study Brief:
Protocol Section:
NCT04683120